STOCK TITAN

[SCHEDULE 13G] Jade Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Jade Biosciences Inc

NASDAQ:JBIO

JBIO Rankings

JBIO Latest News

JBIO Latest SEC Filings

JBIO Stock Data

271.78M
30.30M
0.04%
99%
5.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM